Literature DB >> 23264806

Paraneoplastic Neurologic Disorders: A Brief Overview.

Myrna R Rosenfeld1, Josep Dalmau.   

Abstract

Immune-mediated paraneoplastic neurologic disorders (PND) may affect any part of the nervous system, and can mimic many non-cancer associated disorders. The availability of diagnostic tests based on the presence of specific anti-neuronal antibodies facilitates diagnosis and can suggest treatment strategies. Once thought to be poorly responsive to therapies, it is now recognized that there is a subgroup of PND, mostly associated with antibodies to antigens on the neuronal cell surface that are highly treatment responsive. For all PND, identification and treatment of the underlying tumor is the most effective step in the potential control or stabilization of the neurological disorder.

Entities:  

Year:  2012        PMID: 23264806      PMCID: PMC3525357          DOI: 10.1007/s12254-012-0034-z

Source DB:  PubMed          Journal:  Memo


  20 in total

Review 1.  Paraneoplastic syndromes involving the nervous system.

Authors:  Robert B Darnell; Jerome B Posner
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

2.  Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies.

Authors:  S Vernino; P A Low; R D Fealey; J D Stewart; G Farrugia; V A Lennon
Journal:  N Engl J Med       Date:  2000-09-21       Impact factor: 91.245

3.  Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.

Authors:  C A Vedeler; J C Antoine; B Giometto; F Graus; W Grisold; I K Hart; J Honnorat; P A E Sillevis Smitt; J J G M Verschuuren; R Voltz
Journal:  Eur J Neurol       Date:  2006-07       Impact factor: 6.089

4.  Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.

Authors:  Bruno Giometto; Wolfgang Grisold; Roberta Vitaliani; Francesc Graus; Jérôme Honnorat; Guido Bertolini
Journal:  Arch Neurol       Date:  2010-03

5.  Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor.

Authors:  F Keime-Guibert; F Graus; P Broët; R Reñé; J L Molinuevo; C Ascaso; J Y Delattre
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

6.  Onconeural antibodies in sera from patients with various types of tumours.

Authors:  Sissel Evy Monstad; Anette Knudsen; Helga B Salvesen; Jan H Aarseth; Christian A Vedeler
Journal:  Cancer Immunol Immunother       Date:  2009-03-18       Impact factor: 6.968

7.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

8.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

Review 9.  Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates.

Authors:  Sandip Basu; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2008-02-23       Impact factor: 3.488

Review 10.  Antibodies and neuronal autoimmune disorders of the CNS.

Authors:  Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  J Neurol       Date:  2009-12-25       Impact factor: 4.849

View more
  4 in total

1.  Corneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral Neuropathy.

Authors:  Maryam Ferdousi; Shazli Azmi; Ioannis Nikolaos Petropoulos; Hassan Fadavi; Georgios Ponirakis; Andrew Marshall; Mitra Tavakoli; Imaan Malik; Wasat Mansoor; Rayaz Ahmed Malik
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

Review 2.  Abnormal movements in critical care patients with brain injury: a diagnostic approach.

Authors:  Yousef Hannawi; Michael S Abers; Romergryko G Geocadin; Marek A Mirski
Journal:  Crit Care       Date:  2016-03-14       Impact factor: 9.097

Review 3.  Brain 18F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysis.

Authors:  Manon Bordonne; Mohammad B Chawki; Matthieu Doyen; Aurelie Kas; Eric Guedj; Louise Tyvaert; Antoine Verger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-07       Impact factor: 10.057

4.  High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable phage display.

Authors:  Brian O'Donovan; Caleigh Mandel-Brehm; Sara E Vazquez; Jamin Liu; Audrey V Parent; Mark S Anderson; Travis Kassimatis; Anastasia Zekeridou; Stephen L Hauser; Sean J Pittock; Eric Chow; Michael R Wilson; Joseph L DeRisi
Journal:  Brain Commun       Date:  2020-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.